Andrew Lloyd

Andrew R. Lloyd, MB BS Syd, MD UNSW, FRACP, is an infectious disease physician, and an epidemiology, virology and immunology researcher. He is a professor at the School of Medical Sciences, University of New South Wales, Sydney, Australia.

Awards

 * Member, Order of Australia (A.M): “For service to medicine and the community, particularly through provision of hepatitis services in prisons, and research in infectious diseases”

Clinic

 * The Fatigue Centre, Newtown, New South Wales, Australia, was created and is supervised by Dr. Andrew Lloyd to serve patients with CFS and post-cancer fatigue.

Book Chapters

 * 1999, "Chronic fatigue syndrome: current concepts of pathogenesis and treatment," in Current Clinical Topics in Infectious Diseases, edn. Original
 * 2005, "Fatigue states following infection," in Infectious Diseases A clinical approach, edn. 2

Notable studies

 * 1990, A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome
 * 1997, Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome
 * 1998, Chronic fatigue syndrome: An immunological perspective
 * 2003, Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution (Full Text)
 * 2006, Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: Prospective cohort study (Abstract)
 * 2006, Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus (Full Text)
 * 2006, Prolonged Illness after Infectious Mononucleosis Is Associated with Altered Immunity but Not with Increased Viral Load (Full Text)
 * 2007, Postinfective fatigue syndrome is not associated with altered cytokine production
 * 2007, Fatigue: case definition and guidelines for collection, analysis, and presentation of immunization safety data (Preview)
 * 2010, Serum Cytokine Levels in Postinfective Fatigue Syndrome (Full Text)
 * 2010, Autonomic hyper-vigilance in post-infective fatigue syndrome
 * 2010, Reduced heart rate variability predicts poor sleep quality in a case-control study of chronic fatigue syndrome
 * 2011, Sleep-wake behavior in chronic fatigue syndrome
 * 2012, Reduced Cardiac Vagal Modulation Impacts on Cognitive Performance in Chronic Fatigue Syndrome
 * 2015, Capturing the post-exertional exacerbation of fatigue following physical and cognitive challenge in patients with chronic fatigue syndrome
 * 2016, Fatigue Exacerbation by Interval or Continuous Exercise in Chronic Fatigue Syndrome
 * 2016, Outcomes and predictors of response from an optimised, multidisciplinary intervention for chronic fatigue states
 * 2016, Gene Expression in Response to Exercise in Patients with Chronic Fatigue Syndrome: A Pilot Study (Full Text)
 * 2016, Neurocognitive improvements after best-practice intervention for chronic fatigue syndrome: Preliminary evidence of divergence between objective indices and subjective perceptions
 * 2017, Cytokine signature in chronic fatigue syndrome
 * 2018, Personalised relaxation practice to improve sleep and functioning in patients with chronic fatigue syndrome and depression: study protocol for a randomised controlled trial (Full Text)

Talks & interviews

 * 1-2 September 2014, UK CFS/ME Research Collaborative Conference - Talk title: "Acute infection & post-infective fatigue as a model for CFS"
 * 22 April 2014, Talk to Coogee Owls ME/CFS Support Group at Randwick, Sydney

Online presence

 * UNSW bio page

Learn more

 * 2015, "The Decline and Fall of an ME/CFS Researcher? the Case of Andrew Lloyd" by Cort Johnson for Health Rising
 * 2012, "Model of Post Infective Fatigue Forming: the Dubbo Studies" in Phoenix Rising